AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 91 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $173,000 | -46.8% | 76,324 | -20.5% | 0.02% | -48.6% |
| Q1 2021 | $325,000 | +550.0% | 96,016 | +438.4% | 0.04% | +362.5% |
| Q4 2020 | $50,000 | -74.9% | 17,833 | -77.5% | 0.01% | -75.0% |
| Q3 2020 | $199,000 | +40.1% | 79,240 | +321.8% | 0.03% | +14.3% |
| Q1 2020 | $142,000 | -34.0% | 18,787 | -51.5% | 0.03% | -24.3% |
| Q4 2018 | $215,000 | +121.6% | 38,767 | +252.8% | 0.04% | +184.6% |
| Q3 2018 | $97,000 | -73.4% | 10,989 | -69.9% | 0.01% | -76.4% |
| Q2 2018 | $365,000 | +50.2% | 36,534 | +43.0% | 0.06% | +52.8% |
| Q1 2018 | $243,000 | -41.4% | 25,556 | +21.0% | 0.04% | -46.3% |
| Q3 2017 | $415,000 | +174.8% | 21,115 | +45.4% | 0.07% | +63.4% |
| Q4 2016 | $151,000 | +2.7% | 14,518 | -26.0% | 0.04% | +2.5% |
| Q2 2016 | $147,000 | – | 19,629 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,121,283 | $53,979,000 | 4.02% |
| DAFNA Capital Management LLC | 853,538 | $6,470,000 | 2.70% |
| Baupost Group | 17,527,968 | $132,862,000 | 1.96% |
| Nantahala Capital Management | 6,559,478 | $49,721,000 | 1.86% |
| Novo Holdings A/S | 3,393,039 | $25,719,000 | 1.72% |
| Abrams Capital Management | 5,656,462 | $42,876,000 | 1.69% |
| Stanley-Laman Group, Ltd. | 319,073 | $2,419,000 | 0.73% |
| Integral Health Asset Management, LLC | 200,000 | $1,516,000 | 0.67% |
| KNOTT DAVID M | 135,169 | $1,025,000 | 0.65% |
| Leap Investments LP | 54,700 | $415,000 | 0.61% |